CNS prophylaxis for diffuse large B-cell lymphoma
Autor: | Toby A Eyre, Kerry J Savage, Chan Y Cheah, Tarec C El-Galaly, Katharine L Lewis, Pamela McKay, Matthew R Wilson, Andrew M Evens, Sabela Bobillo, Diego Villa, Matthew J Maurer, Kate Cwynarski, Andrés J M Ferreri |
---|---|
Rok vydání: | 2022 |
Předmět: |
Central Nervous System Neoplasms
Lymphoma Large B-Cell Diffuse/drug therapy Methotrexate Oncology Methotrexate/therapeutic use Antineoplastic Combined Chemotherapy Protocols Central Nervous System Neoplasms/drug therapy Humans Antineoplastic Combined Chemotherapy Protocols/therapeutic use Lymphoma Large B-Cell Diffuse Neoplasm Recurrence Local Neoplasm Recurrence Local/pathology |
Zdroj: | Eyre, T A, Savage, K J, Cheah, C Y, El-Galaly, T C, Lewis, K L, McKay, P, Wilson, M R, Evens, A M, Bobillo, S, Villa, D, Maurer, M J, Cwynarski, K & Ferreri, A J M 2022, ' CNS prophylaxis for diffuse large B-cell lymphoma ', The Lancet Oncology, vol. 23, no. 9, pp. e416-e426 . https://doi.org/10.1016/S1470-2045(22)00371-0 |
ISSN: | 1474-5488 |
DOI: | 10.1016/S1470-2045(22)00371-0 |
Popis: | CNS relapse in the brain parenchyma, eyes, or leptomeninges is an uncommon but devastating complication of diffuse large B-cell lymphoma. CNS prophylaxis strategies, typically involving intrathecal or high-dose antimetabolites, have been developed in the front-line treatment setting with the aim to reduce this subsequent risk. Clinical and biological features associated with elevated risk are increasingly well defined and are discussed in this Review. This Review summarises both the historical and current developments in this challenging field, provides a nuanced discussion regarding current reasons for and against standard prophylactic measures, outlines evidence for the timing of prophylactic measures when delivered, and reflects on possible future developments. |
Databáze: | OpenAIRE |
Externí odkaz: |